A Randomized Trial of Progesterone in Women with Recurrent Miscarriages
Author(s) -
Arri Coomarasamy,
Helen Williams,
Ewa Truchanowicz,
Paul T. Seed,
Rachel Small,
Siobhan Quenby,
Pratima Gupta,
Feroza Dawood,
Yvonne E Koot,
Ruth Bender-Atik,
Kitty W.M. Bloemenkamp,
Rebecca C. Brady,
Annette Briley,
Rebecca Cavallaro,
Ying Cheong,
Justin Chu,
Abey Eapen,
Ayman Ewies,
Annemieke Hoek,
Eugenie M. Kaaijk,
Carolien Koks,
Tin Chiu Li,
Marjory MacLean,
Ben W. Mol,
Jonathan D. Moore,
Jackie Ross,
Lisa Sharpe,
Jane A. Stewart,
Nirmala Vaithilingam,
Roy G. Farquharson,
Mark D. Kilby,
Yacoub Khalaf,
Mariëtte Goddijn,
Lesley Regan,
Rajendra Rai
Publication year - 2015
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1504927
Subject(s) - medicine , gestation , pregnancy , miscarriage , placebo , obstetrics , live birth , randomized controlled trial , gynecology , confidence interval , randomization , pregnancy rate , alternative medicine , pathology , genetics , biology
Progesterone is essential for the maintenance of pregnancy. However, whether progesterone supplementation in the first trimester of pregnancy would increase the rate of live births among women with a history of unexplained recurrent miscarriages is uncertain.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom